Chemical disinfection and inactivation of prions

Prions in Humans and Animals

Volumn , Issue , 2006, Pages 504-514

  Hõrnlimann, Beat ^a   Schulz Schaeffer, Walter J ^b   Roth, Klaus ^c   Yan, Zheng Xin ^c   Müller, Henrik ^d   Oberthür, Radulf C ^e   Riesner, Detlev ^d  

^a BSE71 92 SVISS Consulting   (Switzerland)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c SMP GmbH Testen Validieren Forschen   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e Labor Dr Oberthiir GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859726494     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1515/9783110200171     Document Type: Chapter

References (45)

1. Wilson DR, Anderson RD, Smith W. Studies in scrapie. J Comp Path 1950; 60:267-282.
2. Pattison IH. A sideways look at the scrapie saga: 1732-1991. In: Prusiner SB, Collinge J, Powell J, et al., editors. Prion diseases of humans and animais. Ellis Horwood, New York, 1992:15-22.
3. Alper T, Haig DA, Clarke MC. The exception-ally small size of the scrapie agent. Biochem Bio-phys Res Commun 1966; 22:278-284.
4. Alper T, Cramp WA, Haig DA, et al. Does the agent of scrapie replicate without nucleic acid? Nature 1967; 214:764-766.
5. Parchi P, Zou W, Wang W, et al. Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sei U S A 2005; 97:10168-10172.
6. Barry RA, Kent SB, McKinley MP, et al. Scrapie and cellular prion proteins share polypeptide epi-topes. J Infect Dis 1986; 153:848-854.
7. Prusiner SB and Hsiao KK. Prions causing trans-missible neurodegenerative diseases. In: Schloss-berg D, editor. Infections of the nervous system. Springer, New York, 1990.
8. Brown P, Liberski PP, Wolff A, et al. Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees Celsius: practical and theoretical implications. J Infect Dis 1990; 161:467-472.
9. Dumpitak C, Beekes M, Weinmann N, et al. The polysaccharide scaffold of PrP 27-30 is a com-mon compound of natural prions and consists of alpha-linked polyglucose. Biol Chem 2005: 386(11):1149-1155.
10. Tanford C. Protein denaturation. In: Anfmsen CB Jr, Anson ML, Edsall JT, et al, editors. Ad-vances in protein chemistry. Academic Press, New York, 1968:121-128.
11. Appel TR, Lucassen R, Groschup MH, et al. Acid inactivation of prions - efficient at elevated temperature or high acid concentration. J Gen Virol 2006; 87(5):1385-1394.
12. Roberts JD and Caserio MC. Basic principies of organic chemistry. W.A. Benjamin, New York, 1965.
13. Anonymous. Sichere Biotechnologie - Eingrup-pierung biologischer Agenzien: Stoffmerkblátter der BG Chemie. Merkblatt "Viren" B004 9/96 ZH 1/344: Anhang 3, Abschnitt 3, 1996.
14. Bertram J, Mielke M, Beekes M, et al. Inactivation and remo vai of prions in producing medicai products. A contribution to evaluation and de-claration of possible methods [Inaktivierung und Entfernung von Prionen bei der Aufbereitung von Medizinprodukten], Bundesgesundheits-blatt Gesundheitsforschung Gesundheitsschutz. 2004; 47:36-40.
15. Taylor DM. Inactivation of transmissible degen-erative encephalopathy agents: a review. Vet J 2000; 159(1):10-17.
16. Zobeley E, Flechsig F, Cozzio A, et al. Infec-tivity of scrapie prions bound to a stainless steel surface. Mol Med. 1999; 5:240-243.
17. Yan ZX, Stitz L, Heeg P, et al. Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol 2004; 25:280-283.
18. Lemmer K, Mielke M, Pauli G, et al. Decontamination of surgical instruments from prion pro-teins: in vitro studies on the detachment, destabil-ization and degradation of PrPSc bound to steel surfaces. J Gen Virol 2004; 85(12):3805-3816.
19. Fichet G, Comoy E, Duval C, et al. Novel methods for disinfection of prion-contaminated medicai devices. Lancet 2004; 364:521-526.
20. Brown R BSE: the final resting place. Lancet 1998; 351:1146-1147.
21. Taylor DM. Resistance of transmissible spongiform encephalopathy agents to decontamination. Contrib Microbiol 2004; 11:136-145.
22. Brown P, Rohwer RG, Gajdusek DC. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 1986; 153:1145-1148.
23. Taylor DM, Fraser H, McConnell I, et al. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 1994; 139:313-326.
24. Brown P, Gibbs CJ Jr, Amyx HL, et al. Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med 1982; 306:1279-1282.
25. Taylor KC. The control of bovine spongiform encephalopathy in Great Britain. Vet Rec 1991; 129:522-526.
26. Prusiner SB, Groth D, Serban A, et al. Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc Natl Acad Sei U S A 1993; 90:2793-2797.
27. Seddon HR. Scrapie. In: Seddon HR, editor. Diseases of domestic animais in Austrália - part 4. A.J. Arthur, Commonwealth Government Printer, Canberra, 1958:176.
28. Lapanje S. Physicochemical aspects of protein denaturation. John Wiley & Sons, New York, 1978.
29. Bessen RA, Kocisko DA, Raymond GJ, et al. Non-geneticpropagation of strain-specific prop-erties of scrapie prion protein. Nature 1995; 375:698-700.
30. Oesch B, Jensen M, Nilsson P, et al. Properties of the scrapie prion protein: quantitative analysis of protease resistance. Biochemistry 1994; 33:5926-5931.
31. Manuelidis L. Decontamination of Creutzfeldt-Jakob disease and other transmissible agents. J Neurovirol 1997; 3(l):62-65.
32. Tateishi J, Tashima T, Kitamoto T. Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen. Microbiol Immu-nol 1991; 35:163-166.
33. Flechsig E, Hegyi I, Enari M, et al. Transmission of scrapie by steel-surface-bound prions. Mol Med 2001; 7(10):679-684.
34. Anonymous. Desinfektion und Sterilisation von chirurgischen Instrumenten bei Verdacht auf Creutzfeldt-Jakob-Erkrankungen.Bundesgesundheitsblatt 1996; 39(8/96):282-283.
35. Anonymous. Creutzfeldt-Jakob-Krankheit: Desinfektion und Sterilisation von chirurgischen Instrumenten (Empfehlungen einer Experten-beratung). Epidemiol Bulletin 1996; 27:182-184.
36. Peretz D, Supattapone S, Giles K, et al. Inactivation of prions by acidic sodium dodecyl sulfate. J Virol 2006; 80(1):322-331.
37. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 1990; 40:887-890.
38. Taylor DM, Brown JM, Fernie K, et al. The ef-fect of formic acid on BSE and scrapie infectivity in fixed and unfixed brain-tissue. Vet Microbiol 1997; 58(2-4):167-174.
39. Gonzalez L, Jeffrey M, Siso S, et al. Diagnosis of preclinical scrapiein samples of rectal mucosa. Vet Rec 2005; 156(26):846-847.
40. Baker HF and Ridley RM. Prion diseases. Humana Press, Totowa, NJ, 1996.
41. Baxter HC, Campbell GA, Whittaker AG, et al. Elimination of transmissible spongiform en-cephalopathy infectivity and decontamination of surgical instruments by using radio-frequency gas-plasma treatment. J Gen Virol 2005; 86(8): 2393-2399.
42. Bernoulli C, Siegfried J, Baumgartner G, et al. Danger of accidental person-to-person trans-mission of Creutzfeldt-Jakob disease by surgery [letter], Lancet 1977; l(8009):478-479.
43. Brown P, Rohwer RG, Green EM, et al. Effect of chemicals, heat, and histopathologic process-ing on high-infectivity hamster-adapted scrapie virus. J Infect Dis 1982; 145:683-687.
44. ACDP Transmissible spongiform encepha-lopathy agents: safe working and the prevention of infection. Advisory Committee on Dangerous Pathogens & Spongiform Encephalopathy Advisory Committee. Statutory Office, London 1998.
45. Taylor DM, Fernie K, McConnell I. Inactivation of the 22A strain of scrapie agent by autoclaving in sodium hydroxide. Vet Microbiol 1997; 58(2-4):87-91.